| 11/12/2026 1:36 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/12/2026 8:24 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/12/2026 8:25 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/12/2026 7:45 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/10/2026 3:54 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/10/2026 11:45 AM | Genmab A/S (1434265) Subject Klimovsky Judith V. (1762247) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/05/2026 10:04 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/28/2026 8:43 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/23/2026 10:58 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/13/2026 6:50 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/07/2026 11:27 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for GNMSF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/05/2026 8:30 PM | Darwin Global Management, Ltd. (1839209) Filed by Genmab A/S (1434265) Subject | Form SCHEDULE 13G | |
| 10/05/2026 2:28 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/02/2026 12:51 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/29/2026 9:40 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/24/2026 1:45 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/09/2026 9:43 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/08/2026 6:47 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/14/2026 12:14 PM | Genmab A/S (1434265) Subject ORBIS INVESTMENT MANAGEMENT LTD (940594) Filed by | Form SCHEDULE 13G/A | |
| 08/12/2026 8:49 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/11/2026 1:14 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/06/2026 10:08 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/15/2026 6:22 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/17/2026 10:30 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/16/2026 2:37 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/15/2026 11:08 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/15/2026 10:08 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/11/2026 12:58 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/29/2026 3:41 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/15/2026 12:05 PM | Genmab A/S (1434265) Subject ORBIS INVESTMENT MANAGEMENT LTD (940594) Filed by | Form SCHEDULE 13G/A | |
| 05/13/2026 9:15 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/12/2026 12:53 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/08/2026 3:17 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2026 10:06 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/17/2026 11:20 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/17/2026 10:24 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 11:01 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 7:26 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/01/2026 2:21 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/01/2026 1:44 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/23/2026 9:04 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Bitcoin's problem is its own size (Ad) Bitcoin is trading near $60,000. For your Bitcoin position to double from here, roughly $1.5 trillion in new money has to flow into a single asset. Not impossible.
Now ask what it takes to move a coin with a $40 million market cap. Not a trillion dollars. A fraction of a percent of one.
That's the entire reason my team stopped hunting for the next Bitcoin years ago. I put together a short presentation walking through where we're looking instead, and why the largest percentage moves in this market stopped coming from the coins everyone recognizes. Watch the presentation free here. |
| 03/19/2026 1:34 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/19/2026 9:29 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/16/2026 9:15 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/09/2026 9:16 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/04/2026 10:32 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/02/2026 8:50 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/25/2026 9:51 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/24/2026 2:29 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/23/2026 9:31 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/20/2026 9:07 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/18/2026 9:07 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 11:07 AM | Genmab A/S (1434265) Subject ORBIS INVESTMENT MANAGEMENT LTD (940594) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 10:17 AM | Genmab A/S (1434265) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/03/2026 10:59 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/29/2026 12:32 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/21/2026 6:02 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 12:41 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/30/2025 4:41 PM | Genmab A/S (1434265) Reporting Merus N.V. (1651311) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 4:24 PM | Genmab A/S (1434265) Filed by Merus N.V. (1651311) Subject | Form SCHEDULE 13D/A | |
| 12/30/2025 6:52 AM | Genmab A/S (1434265) Filed by Merus N.V. (1651311) Subject | Form SC TO-T/A | |
| 12/29/2025 4:16 PM | Genmab A/S (1434265) Reporting Merus N.V. (1651311) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 7:27 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 4:15 PM | Genmab A/S (1434265) Reporting Merus N.V. (1651311) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/19/2025 11:32 AM | Genmab A/S (1434265) Filed by Merus N.V. (1651311) Subject | Form SCHEDULE 13D | |
| 12/18/2025 4:54 PM | Genmab A/S (1434265) Reporting Merus N.V. (1651311) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 4:49 PM | Genmab A/S (1434265) Reporting Merus N.V. (1651311) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/12/2025 6:45 AM | Genmab A/S (1434265) Filed by Merus N.V. (1651311) Subject | Form SC TO-T/A | |
| 12/12/2025 6:00 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/09/2025 3:14 PM | Genmab A/S (1434265) Filed by Merus N.V. (1651311) Subject | Form SC TO-T/A | |
| 12/01/2025 3:46 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/26/2025 6:04 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/20/2025 2:22 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/19/2025 1:35 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/19/2025 11:48 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 2:04 PM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 11:10 AM | Genmab A/S (1434265) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |